News
Effects of income, competition and procurement on drug prices in emerging markets
2014-05-29 Drugs are least affordable relative to income in low-income countries, according to an analysis of income, competition and procurement on drug prices in emerging markets… Read More »
Switching to generic cyclosporine A after heart transplant safe
2014-05-27 Cyclosporine A is an immunosuppressant drug widely used in organ transplantation to prevent rejection. A study of switching between originator and generic drugs showed that… Read More »
EU problematic patent settlements remain at low level
2014-05-22 The European Commission’s (EC) fourth monitoring exercise of patent settlements in the pharmaceutical sector has shown the number of potentially problematic settlements under EU antitrust… Read More »
Biosimilar trastuzumab approved in Korea
2014-05-20 South Korean biotechnology company Celltrion announced on 15 January 2014 that it had received approval for its biosimilar monoclonal antibody Herzuma (trastuzumab) with the Korean… Read More »
J&J adds its opinion to biosimilars naming debate
2014-05-15 In the ongoing saga over how to name biosimilars healthcare giant Johnson & Johnson (J&J) has added its opinion to the melting pot; petitioning the… Read More »
Germany wants to increase biosimilars penetration
2014-05-13 Germany may introduce regulations to increase the uptake of biosimilars in the country, according to Mr Mathias Heck, who serves as the European Union Legal… Read More »
Shortage of HIV/AIDS drugs in South Africa
2014-05-08 According to a survey of South African clinics, one in five of them are running short of life-saving HIV/AIDS drugs, affecting nearly half a million… Read More »
OECD report finds reduction in spending on health
2014-05-01 Spending on health fell in one of three countries covered by the Organisation for Economic Co-operation and Development (OECD) between 2009 and 2011, with the… Read More »
Pennsylvania moves closer to adopting biosimilars legislation
2014-04-29 Pennsylvania has taken a step closer to adopting legislation which would authorize pharmacists to be able to substitute FDA-approved biosimilars for their reference biologicals, but… Read More »
Survey highlights the importance of unique names for biosimilars
2014-04-24 A report released by the Alliance for Safe Biologic Medicines (ASBM) on 22 November 2013 highlights the importance of using unique names for identifying biosimilars.… Read More »
